NYSE Composite ended the session with AbbVie rising 2.85% to $114.68 on Monday while nYSE Composite jumped 0.64% to $16,323.82.
AbbVie today’s close was $114.68, 0.37% below its 52-week high of $115.10.
AbbVie’s sales growth is 34.3% for the current quarter and 10.2% for the next. The company’s growth estimates for the present quarter and the next is 30.8% and 14.5%, respectively.
Year-on-year quarterly revenue growth grew by 50.9%, now sitting on 50.2B for the twelve trailing months.
AbbVie’s Stock Yearly Top and Bottom Value
AbbVie’s stock is valued at $114.68 at 17:04 EST, below its 52-week high of $115.10 and way above its 52-week low of $74.78.
AbbVie’s Moving Average
AbbVie’s worth is above its 50-day moving average of $106.61 and way above its 200-day moving average of $100.54.
More news about AbbVie.